Caminiti Caterina, Iezzi Elisa, Passalacqua Rodolfo
Research and Innovation Unit, University Hospital of Parma, Parma, Italy.
Division of Medical Oncology, Hospital of Cremona, Cremona, Italy.
BMJ Open. 2017 Oct 6;7(10):e016347. doi: 10.1136/bmjopen-2017-016347.
Our group previously demonstrated the feasibility of the HuCare Quality Improvement Strategy (HQIS), aimed at integrating into practice six psychosocial interventions recommended by international guidelines. This trial will assess whether the introduction of the strategy in oncology wards improves patient's health-related quality of life (HRQoL).
Multicentre, incomplete stepped-wedge cluster randomised controlled trial, conducted in three clusters of five centres each, in three equally spaced time epochs. The study also includes an initial epoch when none of the centres are exposed to the intervention, and a final epoch when all centres will have implemented the strategy. The intervention is applied at a cluster level, and assessed at an individual level with cross-sectional model. A total of 720 patients who received a cancer diagnosis in the previous 2 months and about to start medical treatment will be enrolled. The primary aim is to evaluate the effectiveness of the HQIS versus standard care in terms of improvement of at least one of two domains (emotional and social functions) of HRQoL using the EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items) questionnaire, at baseline and at 3 months. This outcome was chosen because patients with cancer generally exhibit low HRQoL, particularly at certain stages of care, and because it allows to assess the strategy's impact as perceived by patients themselves. The HQIS comprises three phases: (1) clinician training-to improve communication-relational skills and instruct on the project; (2) centre support-four on-site visits by experts of the project team, aimed to boost motivation, help with context analysis and identification of solutions; (3) implementation of Evidence-Based Medicine (EBM) recommendations at the centre.
Ethics committee review approval has been obtained from the Ethics Committee of Parma. Results will be disseminated at conferences, and in peer-reviewed and professional journals intended for policymakers and managers.
NCT03008993; Pre-results.
我们的团队之前证明了HuCare质量改进策略(HQIS)的可行性,该策略旨在将国际指南推荐的六种心理社会干预措施融入实践。本试验将评估在肿瘤病房引入该策略是否能改善患者的健康相关生活质量(HRQoL)。
多中心、不完全阶梯式楔形整群随机对照试验,在三个集群中进行,每个集群包含五个中心,分三个等距的时间段。该研究还包括一个初始阶段,此时所有中心均未接受干预,以及一个最终阶段,此时所有中心都将实施该策略。干预在集群层面实施,并通过横断面模型在个体层面进行评估。总共将招募720名在过去2个月内被诊断患有癌症且即将开始接受治疗的患者。主要目的是使用欧洲癌症研究与治疗组织生活质量问卷核心30项(EORTC QLQ-C30)问卷,在基线和3个月时,评估HQIS与标准护理相比,在改善HRQoL的两个领域(情感和社会功能)中至少一个领域方面的有效性。选择这一结果是因为癌症患者通常HRQoL较低,尤其是在护理的某些阶段,并且因为它能够评估患者自身所感受到的该策略的影响。HQIS包括三个阶段:(1)临床医生培训——提高沟通关系技能并就项目进行指导;(2)中心支持——项目团队专家进行四次现场访问,旨在增强动力、帮助进行背景分析和确定解决方案;(3)在中心实施循证医学(EBM)建议。
已获得帕尔马伦理委员会的伦理委员会审查批准。结果将在会议上以及面向政策制定者和管理人员的同行评审专业期刊上发表。
NCT03008993;预结果。